PPA
ORIC icon

Parametric Portfolio Associates’s Oric Pharmaceuticals ORIC Stock Holding History

Parametric Portfolio Associates’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$70K Sell
13,097
-50,131
-79% -$451K ﹤0.01% 3603
2021
Q4 		$929K Buy
63,228
+7,073
+13% +$110K ﹤0.01% 2811
2021
Q3 		$1.17M Buy
56,155
+20,574
+58% +$417K ﹤0.01% 2730
2021
Q2 		$629K Sell
35,581
-2,303
-6% -$50.5K ﹤0.01% 2986
2021
Q1 		$928K Buy
37,884
+10,190
+37% +$322K ﹤0.01% 3200
2020
Q4 		$937K Buy
27,694
+3,256
+13% +$93.4K ﹤0.01% 3082
2020
Q3 		$611K Buy
24,438
+1,000
+4% +$23.8K ﹤0.01% 3175
2020
Q2 		$791K Buy
+23,438
New +$748K ﹤0.01% 3047

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return